Latest News and Press Releases
Want to stay updated on the latest news?
-
Zaandam, the Netherlands, November 3, 2014 - Ahold has repurchased 196,490 Ahold common shares in the period from October 27, 2014 up to and including October 31, 2014. The shares were repurchased...
-
Tallinn, Estonia, 2014-11-03 08:00 CET (GLOBE NEWSWIRE) --...
-
Riga, Latvia, 2014-11-03 08:00 CET (GLOBE NEWSWIRE) --...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} Aluminium company Hydro and Rio Tinto Alcan (RTA)...
-
Kambi is pleased to announce Redeye AB as its new Certified Advisor, with effect from 1 November 2014. As planned, Redeye AB replaces SEB Corporate Finance, who assisted Kambi during its listing...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} BOUSSARD...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} BOUSSARD...
-
Group CEO Trond Williksen has today exercised 120,000 options to receive shares in AKVA group ASA at a strike price of NOK 14.00 per share. The options were granted under an option agreement...
-
body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} IPH4102 is a first-in-class anti-KIR3DL2...
-
Basel, Switzerland, November 3, 2014 - Basilea Pharmaceutica Ltd. (SIX: BSLN) reports today that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation to isavuconazole for...